John Buse, Director of the Diabetes Care Center at the University of North Carolina and a principal investigator in GLP-1 outcomes trials, has noted in published commentary that "the antioxidant milieu in type 2 diabetes is genuinely impaired, but whether exogenous supplementation corrects the underlying defect or simply raises circulating levels without tissue impact remains unresolved." [9] That distinction shapes the practical advice: correcting a documented deficiency (measured low whole-blood glutathione in a patient with poorly controlled diabetes) is a different clinical decision from empirically adding glutathione to a well-controlled patient already benefiting from dulaglutide's own oxidative-stress effects
By law, Medicare is not allowed to cover weight-loss drugs, though a drug commonly used for weight loss may be covered for other indications, such as diabetes
If you were on any dietary restrictions for other medical reasons, continue those as instructed by your doctor or dietitian
Experimental investigations have demonstrated that cholangiocytes are sensitive to GLP-1 and respond with augmented proliferation, potentially increasing the risk of duct obstruction [47,48]
Chronic Condition Care Managing chronic conditions care is essential for maintaining long-term health and quality of life